- Home
- PODC vs NEPH Comparison
PODC vs NEPH Comparison
Compare PODC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- NEPH
- Stock Information
- Founded
- PODC 2013
- NEPH 1997
- Country
- PODC United States
- NEPH United States
- Employees
- PODC N/A
- NEPH N/A
- Industry
- PODC
- NEPH Medical/Dental Instruments
- Sector
- PODC
- NEPH Health Care
- Exchange
- PODC Nasdaq
- NEPH Nasdaq
- Market Cap
- PODC 44.1M
- NEPH 36.1M
- IPO Year
- PODC N/A
- NEPH 2004
- Fundamental
- Price
- PODC $2.40
- NEPH $4.00
- Analyst Decision
- PODC
- NEPH Buy
- Analyst Count
- PODC 0
- NEPH 1
- Target Price
- PODC N/A
- NEPH $5.00
- AVG Volume (30 Days)
- PODC 86.3K
- NEPH 66.3K
- Earning Date
- PODC 06-18-2025
- NEPH 08-07-2025
- Dividend Yield
- PODC N/A
- NEPH N/A
- EPS Growth
- PODC N/A
- NEPH N/A
- EPS
- PODC N/A
- NEPH 0.08
- Revenue
- PODC $52,119,000.00
- NEPH $15,517,000.00
- Revenue This Year
- PODC $19.39
- NEPH $17.06
- Revenue Next Year
- PODC $23.41
- NEPH $12.20
- P/E Ratio
- PODC N/A
- NEPH $54.66
- Revenue Growth
- PODC 20.36
- NEPH 10.34
- 52 Week Low
- PODC $1.10
- NEPH $1.36
- 52 Week High
- PODC $2.85
- NEPH $5.00
- Technical
- Relative Strength Index (RSI)
- PODC 68.42
- NEPH 61.33
- Support Level
- PODC $1.83
- NEPH $4.00
- Resistance Level
- PODC $2.75
- NEPH $5.00
- Average True Range (ATR)
- PODC 0.25
- NEPH 0.49
- MACD
- PODC 0.06
- NEPH 0.01
- Stochastic Oscillator
- PODC 80.00
- NEPH 55.56
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.